title: [Classification criteria of scleroderma].
abstract: Classification criteria of scleroderma aim to delineate the different clinical forms of the disease, which are associated with different prognoses. The basic classification between localized and systemic scleroderma remains pertinent. Among the former, the problems are essentially esthetic or sometimes functional; but the second may yield many other problems which are pertinent to function but also to life, owing to the involvement of body organs, including lungs, heart, digestive tract, kidneys and locomotor system. Overall, the quality of life of scleroderma patients is often poor. The patients are subclassified according to the skin involvement. Those patients with systemic scleroderma involving the trunk are classified as "Cutaneous diffuse systemic scleroderma"; the association of Raynaud's phenomenon, capillaroscopic abnormalities and specific autoantibodies defines "limited systemic scleroderma"; among the latter patients, those with distal skin involvement are classified "Cutaneous limited systemic sclerosis". The old term "CREST" tends to be abandoned due to its lack of specificity.
authors.affiliation: Service de Médecine Interne, Hôpital Saint-Antoine, Paris. jean.cabane@sat.ap-hop-paris.fr
authors.forename: Jean
authors.initials: J
authors.lastname: Cabane
mesh_terms: D015415:Biomarkers; D006801:Humans; D011379:Prognosis; D011788:Quality of Life; D011928:Raynaud Disease / Q000175:diagnosis; D045743:Scleroderma, Diffuse / Q000145:classification / Q000175:diagnosis / Q000276:immunology; D045745:Scleroderma, Limited / Q000145:classification / Q000175:diagnosis / Q000276:immunology; D012595:Scleroderma, Systemic / Q000145:classification* / Q000175:diagnosis / Q000276:immunology; D013997:Time Factors
chemical_list: D015415:Biomarkers